BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17308069)

  • 1. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
    Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
    Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk.
    Agrawal A; Guttapalli A; Narayan S; Albert TJ; Shapiro IM; Risbud MV
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C621-31. PubMed ID: 17442734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
    Maher JC; Savaraj N; Priebe W; Liu H; Lampidis TJ
    Pancreas; 2005 Mar; 30(2):e34-9. PubMed ID: 15714127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
    Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
    Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
    Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
    Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
    Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
    Wangpaichitr M; Savaraj N; Maher J; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2008 Jun; 7(6):1506-13. PubMed ID: 18566221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells.
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX
    J Exp Clin Cancer Res; 2005 Dec; 24(4):565-74. PubMed ID: 16471319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
    J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma.
    Pistollato F; Abbadi S; Rampazzo E; Viola G; Della Puppa A; Cavallini L; Frasson C; Persano L; Panchision DM; Basso G
    Biochem Pharmacol; 2010 Nov; 80(10):1517-27. PubMed ID: 20705058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
    Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
    Maher JC; Krishan A; Lampidis TJ
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):116-22. PubMed ID: 14605866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.